Novo Nordisk
NVO
#32
Rank
$240.48 B
Marketcap
$106.04
Share price
1.62%
Change (1 day)
34.06%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2022 (TTM): $9.55 B

According to Novo Nordisk's latest financial reports the company's current earnings (TTM) are $9.55 B. In 2021 the company made an earning of $9.29 B an increase over its 2020 earnings that were of $8.26 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Novo Nordisk from 2001 to 2022

Year Earnings Change
2022 (TTM)$9.55 B2.87%
2021$9.29 B12.47%
2020$8.26 B13.07%
2019$7.30 B-3.35%
2018$7.55 B1.79%
2017$7.42 B4.52%
2016$7.10 B9.42%
2015$6.49 B8.24%
2014$5.99 B3.45%
2013$5.79 B19.02%
2012$4.87 B15.21%
2011$4.22 B17.71%
2010$3.59 B24.78%
2009$2.87 B16.62%
2008$2.46 B47.95%
2007$1.66 B7.07%
2006$1.55 B18.18%
2005$1.31 B13.43%
2004$1.16 B24.1%
2003$0.93 B11.07%
2002$0.84 B-14.39%
2001$0.98 B